REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot144410.32687/1561-5936-2022-26-3-199-204Review articleReproductive technologies in solving the problems of infertility of the population (Part I)TliashinovaI. A.-SadykovaR. N.-MingazovaE. N.elmira_mingazova@mail.ruN. A. Semashko National Research Institute of Public HealthI. M. Sechenov First Moscow State Medical University (Sechenov University)Pirogov Russian National Research Medical UniversityKazan State Medical University1512202226319920421092022Copyright © 2022,2022The article provides an overview of scientific information on modern approaches to reproductive health protection, innovative methods for early detection of disorders and timely correction of reduced reproductive capabilities of the body, including infertility. The main physiological factors of reproductive disorders are genetic predisposition, mitochondrial dysfunctions, genomic instability, oxidative stress, etc. In particular, mitochondria make a significant contribution to the regulation of various physiological aspects of reproductive function, including the development of oocytes and embryos, as well as spermatogenesis and fertilization. Oocyte dysfunction associated with aging is becoming an increasingly pressing medical and economic problem in modern society, where women are postponing family formation. Maternal metabolic disorders such as obesity and type II diabetes are associated with hyperlipidemia and increased concentrations of free fatty acids in ovarian follicular fluid. Oocyte maturation under these lipotoxic conditions leads to increased levels of oxidative stress, mitochondrial dysfunction, decreased competence in oocyte development, and poor IVF results.As a result, it was revealed which modern approaches influence the solution of the problem of reproductive disorders, the risk factors for reproductive health were assessed, and methods were proposed to reduce the influence of these factors.reproductive disordersmitochondrial dysfunctionsmethods of correctionнарушения репродуктивных функциймитохондриальные дисфункцииметоды коррекцииSfakianoudis K., Rapani A., Grigoriadis S. et al. Novel approaches in addressing ovarian insufficiency in 2019: are we there yet? // Cell Transplant. 2020. Vol. 29. P. 963689720926154. DOI: 10.1177/0963689720926154May-Panloup P., Boguenet M., Hachem H. E. et al. Embryo and its mitochondria // Antioxidants (Basel). 2021. Vol. 10, N 2. P. 139. DOI: 10.3390/antiox10020139Sharma P., Sampath H. Mitochondrial DNA integrity: role in health and disease // Cells. 2019. Vol. 8, N 2. P. 100. DOI: 10.3390/cells8020100Durairajanayagam D., Singh D., Agarwal A., Henkel R. Causes and consequences of sperm mitochondrial dysfunction // Andrologia. 2021. Vol. 53, N 1. P. e13666. DOI: 10.1111/and.13666Chiaratti M. R., Garcia B. M., Carvalho K. F. et al. The role of mitochondria in the female germline: Implications to fertility and inheritance of mitochondrial diseases // Cell Biol Int. 2018. Vol. 42, N 6. P. 711-724. DOI: 10.1002/cbin.10947Fu L., Luo Y. X., Liu Y. et al. Potential of mitochondrial genome editing for human fertility health // Front. Genet. 2021. Vol. 12. P. 67395. DOI: 10.3389/fgene.2021.67395Roth Z. Symposium review: reduction in oocyte developmental competence by stress is associated with alterations in mitochondrial function // J Dairy Sci. 2018. Vol. 101, N 4. P. 3642-3654. DOI: 10.3168/jds.2017-13389Zou W., Slone J., Cao Y., Huang T. Mitochondria and their role in human reproduction // DNA Cell Biol. 2020. Vol. 39, N 8. P. 1370-1378. DOI: 10.1089/dna.2019.4807Boguenet M., Bouet P. E., Spiers A. et al. Mitochondria: their role in spermatozoa and in male infertility // Hum. Reprod. Update. 2021. Vol. 27, N 4. P. 697-719. DOI: 10.1093/humupd/dmab001Luo S., Valencia C. A., Zhang J. et al. Biparental inheritance of mitochondrial DNA in humans // Proc. Natl. Acad. Sci. USA. 2018. Vol. 115, N 51. P. 13039-13044. DOI: 10.1073/pnas.1810946115Wei W., Pagnamenta A. T., Gleadall N. et al. Nuclear-mitochondrial DNA segments resemble paternally inherited mitochondrial DNA in humans // Nat.Commun. 2020. Vol. 11, N 1. P. 1740. DOI: 10.1038/s41467-020-15336-3Marei W. F. A., Van den Bosch L., Pintelon I. et al. Mitochondria-targeted therapy rescues development and quality of embryos derived from oocytes matured under oxidative stress conditions: a bovine in vitro model // Hum. Reprod. 2019. Vol. 34, N 10. P. 1984-1998. DOI: 10.1093/humrep/dez161Fabozzi G., Iussig B., Cimadomo D. et al. The impact of unbalanced maternal nutritional intakes on oocyte mitochondrial activity: implications for reproductive function // Antioxidants (Basel). 2021. Vol. 10, N 1. P. 91. DOI: 10.3390/antiox10010091Tao Y., Tartia A., Lawson M. et al. Can peri-ovulatory putrescine supplementation improve egg quality in older infertile women? //j. Assist. Reprod. Genet. 2019. Vol. 36, N 3. P. 395-402. DOI: 10.1007/s10815-018-1327-xShpilka T, Haynes C. M. The mitochondrial UPR: mechanisms, physiological functions and implications in ageing // Nat. Rev. Mol Cell Biol. 2018. Vol. 19, N 2. P. 109-120. DOI: 10.1038/nrm.2017.110May-Panloup P., Boucret L., Chao de la Barca J. M. et al. Ovarian ageing: the role of mitochondria in oocytes and follicles // Hum. Reprod. Update. 2016. Vol. 22, N 6. P. 725-743. DOI: 10.1093/humupd/dmw028Rai P. K., Craven L., Hoogewijs K. et al. Advances in methods for reducing mitochondrial DNA disease by replacing or manipulating the mitochondrial genome // Essays Biochem. 2018. Vol. 62, N 3. P. 455-465. DOI: 10.1042/EBC20170113